CryoPort Inc Stock OTC Bulletin Board
Equities
US2290502085
Air Freight & Logistics
End-of-day quote
Other stock markets
|
||
- USD | - |
06-20 | Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies | CI |
05-07 | Transcript : Cryoport, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Sales 2024 * | 242M 332M | Sales 2025 * | 266M 364M | Capitalization | 478M 654M |
---|---|---|---|---|---|
Net income 2024 * | -68M -93.12M | Net income 2025 * | -55M -75.32M | EV / Sales 2024 * | 2.08 x |
Net Debt 2024 * | 26.51M 36.3M | Net Debt 2025 * | 52.1M 71.34M | EV / Sales 2025 * | 1.99 x |
P/E ratio 2024 * |
-6.89
x | P/E ratio 2025 * |
-8.75
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.44% |
Latest transcript on CryoPort Inc
Managers | Title | Age | Since |
---|---|---|---|
Jerrell Shelton
CEO | Chief Executive Officer | 76 | 12-10-21 |
Director of Finance/CFO | 59 | 11-06-26 | |
Mark Sawicki
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Berman
BRD | Director/Board Member | 81 | 14-12-31 |
Linda Baddour
BRD | Director/Board Member | 65 | 21-03-14 |
Jerrell Shelton
CEO | Chief Executive Officer | 76 | 12-10-21 |
1st Jan change | Capi. | |
---|---|---|
-14.72% | 6.53B | |
+47.74% | 6.14B | |
+2.54% | 3.53B | |
+21.90% | 2.46B | |
+5.06% | 964M | |
+11.35% | 756M | |
-10.15% | 444M | |
-42.51% | 412M | |
-18.65% | 396M |